Page last updated: 2024-12-07

3-(4'-hydroxyl-3',5'-dimethoxyphenyl)propionic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-(4'-hydroxyl-3',5'-dimethoxyphenyl)propionic acid: from Korean cabbage kimchi [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID84681
CHEBI ID174167
SCHEMBL ID490990
MeSH IDM0517966

Synonyms (28)

Synonym
CHEBI:174167
dihydrosinapic acid
3-(4-hydroxy-3,5-dimethoxyphenyl)propanoic acid
14897-78-0
3-(4-hydroxy-3,5-dimethoxyphenyl)propionic acid
benzenepropanoic acid, 4-hydroxy-3,5-dimethoxy-
hydroxinapinic acid
einecs 238-966-2
unii-zz1sho4617
zz1sho4617 ,
AKOS023704166
4-hydroxy-3,5-dimethoxyhydrocinnamic acid
hydrocinnamic acid, 4-hydroxy-3,5-dimethoxy-
3-(4'-hydroxyl-3',5'-dimethoxyphenyl)propionic acid
SCHEMBL490990
SY026462
mfcd00016559
3-(3,5-dimethoxy-4-hydroxyphenyl)propionic acid
DTXSID10164147
hydroxinapinic acid, aldrichcpr
3-(4-hydroxy-3,5-dimethoxy-phenyl)-propionic acid
FT-0704614
Q10395562
AC1676
CS-11614
EN300-258015
beta-(3 5-dimethoxy-4-hydroxyphenyl)propionic acid
CS-0215532

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" These results suggested that HDMPPA could maintain NO bioavailability through an increasing eNOS expression and preventing NO degradation by ROS."( Beneficial effects of the active principle component of Korean cabbage kimchi via increasing nitric oxide production and suppressing inflammation in the aorta of apoE knockout mice.
Choi, YH; Noh, JS; Song, YO, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
benzenesAny benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives.
monocarboxylic acidAn oxoacid containing a single carboxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.84

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.84 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.84)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]